益肾化湿颗粒联合达格列净治疗糖尿病肾病脾肾气虚证临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.2

基金项目:


Clinical Study on Yishen Huashi Granules Combined with Dapagliflozin for Diabetic Nephropathy with Spleen-Kidney Qi Deficiency Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察益肾化湿颗粒联合达格列净治疗糖尿病肾病(DN) 脾肾气虚证的临床疗效及对血小板 反应蛋白1(TSP-1)、可溶性Axl 受体酪氨酸激酶(sAxl) 水平的影响。方法:采用随机数字表法将88 例DN 脾肾气虚证患者分为对照组与观察组各44 例。对照组给予单纯达格列净治疗,观察组给予益肾化湿颗粒联合 达格列净治疗。比较2 组治疗前后中医证候积分、肾脏功能指标、血糖指标、TSP-1、sAxl 水平,评估2 组临 床疗效及不良反应发生情况。结果:治疗后,观察组总有效率93.18%,高于对照组77.27%(P<0.05)。治疗 后,2 组中医证候积分、尿白蛋白/肌酐比值(UACR)、尿白蛋白排泄率(UAER)、空腹血糖(FBG)、餐后2 h 血糖(P2hBG)、糖化血红蛋白(HbA1c)、TSP-1、sAxl 水平均低于治疗前(P<0.05), 肾小球滤过 率(eGFR) 水平高于治疗前(P<0.05),且观察组治疗后UACR、UAER、TSP-1、sAxl 水平及血糖指标均低 于对照组(P<0.05),eGFR 水平高于对照组(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P> 0.05)。结论:益肾化湿颗粒联合达格列净治疗DN 脾肾气虚证疗效显著,能有效改善患者肾脏功能,控制血 糖,降低TSP-1、sAxl 水平,安全性较高。

    Abstract:

    Abstract:Objective:To observe the clinical effect of the therapy of Yishen Huashi Granules combined with Dapagliflozin on diabetic nephropathy (DN) with spleen-kidney qi deficiency syndrome and its effects on the levels of thrombospondin- 1 (TSP- 1) and soluble Axl receptor tyrosine kinase (sAxl). Methods: A total of 88 DN patients with spleen-kidney qi deficiency syndrome were divided into the control group and the observation group according to the random number table method, with 44 cases in each group. The control group was given Dapagliflozin for treatment, and the observation group was treated with Yishen Huashi Granules combined with Dapagliflozin. The traditional Chinese medicine (TCM) syndrome scores, levels of kidney function indexes, blood sugar indexes, and levels of TSP- 1 and sAxl were compared between the two groups;the clinical effects and the incidence of adverse reactions in the two groups were evaluated. Results:After treatment,the total effective rate was 93.18% in the observation group,higher than that of 77.27% in the control group (P<0.05). After treatment,the TCM syndrome scores,and the levels of urine albumin creatinine ratio (UACR), urinary albumin excretion rate (UAER), fasting blood glucose (FBG),2-hour postprandial glucose (P2hBG) and hemoglobin A1c (HbA1c),TSP-1 and sAxl in the two groups were lower than those before treatment (P<0.05),and the estimated glomerular filtration rate (eGFR) levels were higher than those before treatment (P<0.05); the levels of UACR, UAER, TSP- 1, sAxl and blood sugar indexes in the observation group were lower than those in the control group (P< 0.05), and the eGFR level was higher than that in the control group (P<0.05). There was no significant difference being found in the comparison of incidence of adverse reactions between the two groups (P> 0.05). Conclusion: The therapy of Yishen Huashi Granules combined with Dapagliflozin has a significant curative effect on DN with spleen-kidney qi deficiency syndrome,which can effectively improve the kidney function of patients,control the blood sugar and decrease the levels of TSP-1 and sAxl with great safety.

    参考文献
    相似文献
    引证文献
引用本文

张瑞霞,左来孟,宋琼.益肾化湿颗粒联合达格列净治疗糖尿病肾病脾肾气虚证临床研究[J].新中医,2024,56(5):90-94

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-03-14
  • 出版日期:
文章二维码